UOC
ESPR

UBS O'Connor’s Esperion Therapeutics ESPR Stock Holding History

UBS O'Connor’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-142,418
Closed -$382K – 591
2024
Q1 		$382K Sell
142,418
-384,705
-73% -$935K 0.01% 354
2023
Q4 		$1.58M Sell
527,123
-104,824
-17% -$136K 0.05% 213
2023
Q3 		$619K Buy
631,947
+335,000
+113% +$485K 0.01% 378
2023
Q2 		$413K Buy
296,947
+90,688
+44% +$127K 0.01% 460
2023
Q1 		$328K Buy
+206,259
New +$1.06M 0.01% 493
2022
Q4 		– Sell
-77,000
Closed -$516K – 112
2022
Q3 		$516K Buy
+77,000
New +$529K 0.01% 810

Other funds holding ESPR

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return